Effectiveness and safety of apixaban, low-molecular weight heparin, and warfarin among high-risk subgroups of venous thromboembolism patients with active cancer

被引:0
|
作者
Cohen, A. [1 ]
Keshishian, A. [2 ]
Lee, T. [3 ]
Wygant, G. [4 ]
Rosenblatt, L. [4 ]
Hlavacek, P. [3 ]
Sah, J. [2 ]
Luo, X. [5 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Dept Hematol Med, Kings Coll London, London, England
[2] STATinMED Res, Ann Arbor, MI USA
[3] Pfizer Inc, New York, NY USA
[4] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[5] Pfizer Inc, Groton, CT 06340 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3369 / 3369
页数:1
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of apixaban and low-molecular weight heparin among patients with venous thromboembolism and active cancer in an extended treatment setting
    Cohen, A. T.
    Dhamane, A. D.
    Liu, X.
    Han, S.
    Stellhorn, R.
    Zhang, Q.
    Singh, R.
    Wang, J.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [2] Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A US Claims Data Analysis
    Cohen, Alexander
    Keshishian, Allison
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Mardekian, Jack
    Wiederkehr, Daniel
    Sah, Janvi
    Luo, Xuemei
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 383 - 395
  • [3] Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancer
    Cohen, Alexander T.
    Keshishian, Allison
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Sah, Janvi
    Luo, Xuemei
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1467 - 1482
  • [4] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    PLOS ONE, 2022, 17 (09):
  • [5] Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale
    Cohen, Alexander T.
    Keshishian, Allison
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Mardekian, Jack
    Wiederkehr, Daniel
    Sah, Janvi
    Luo, Xuemei
    BLOOD, 2019, 134
  • [6] Effectiveness and Safety of Extended Treatment Apixaban Versus Low-Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism
    Cohen, Alexander T.
    Dhamane, Amol D.
    Liu, Xuejun
    Singh, Risho
    Han, Stella
    Stellhorn, Robert
    Wang, Jane
    Luo, Xuemei
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (06): : 397 - 403
  • [7] Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients
    Deusenberry, Christina M.
    Bardsley, Casey
    Sharon, Mindy
    Hobbs, Gerald R.
    Wilson, Alison M.
    Bardes, James M.
    AMERICAN SURGEON, 2023, 89 (12) : 5837 - 5841
  • [8] Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Dietrich, Eric
    Lo-Ciganic, Wei-Hsuan
    Park, Haesuk
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (03) : 188 - 195
  • [9] Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
    Coleman, Craig I.
    Caroti, Kimberly Snow
    Abdelgawwad, Khaled
    Psaroudakis, George
    Fatoba, Samuel
    Rivera, Marcela
    Schaefer, Bernhard
    Brobert, Gunnar
    Khorana, Alok A.
    Becattini, Cecilia
    Lee, Agnes Y. Y.
    Ekbom, Anders
    Carrier, Marc
    Brescia, Christopher
    Cohen, Alexander T.
    JACC: CARDIOONCOLOGY, 2023, 5 (02): : 189 - 200
  • [10] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1940 - 1940